XERS Xeris Biopharma Holdings, Inc.
Healthcare$6.19-2.98%ClosedMarket Cap: $1.07B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$9.00
Target (Median)
$9.00
Target Range
$9.00 - $9.00
Upside from current price: 45.4%
Rating Distribution
1 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-02 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-09 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-07 | Piper Sandler | maintain | Neutral | Neutral |
| 2025-11-07 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-07 | Oppenheimer | maintain | Outperform | Outperform |
| 2025-09-17 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-08-19 | Leerink Partners | maintain | Outperform | Outperform |
| 2025-08-08 | Craig-Hallum | maintain | Buy | Buy |
| 2025-08-08 | Oppenheimer | maintain | Outperform | Outperform |
| 2025-06-05 | Leerink Partners | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $0.37 | $473.6M | 4 |
| Sun Dec 31 | $0.59 | $542.7M | 6 |
| Mon Dec 31 | $0.94 | $623.7M | 4 |
| Tue Dec 31 | $1.12 | $704.5M | 2 |